The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Tresiba
Lantus: Lethal or Lifesaver? #DOC #gbdoc
Summary Following issues I experienced with Lantus (Insulin Glargine) in November 2014, I spent some time researching it, looking at absorption and pharmacokinetics and other […]